Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pancreatic Adenocarcinoma Signature Stratification for Treatment

NCT04469556 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT04469556
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04469556 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pancreatic Adenocarcinoma Signature Stratification for Treatment
Lead sponsor
University Health Network, Toronto
Phase
Phase 2
Overall status
Completed
Start date
October 14, 2020
Completion date
March 5, 2025
Enrollment
150 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

advanced pancreatic cancer, pancreatic cancer metastatic, pancreatic ductal adenocarcinoma